Increased maternal Serum-AFP as an indication for further steps in diagnosis;APF-Erhohung im mutterlichen Serum als Indikation zur invasiven Diagnostik

Zentralblatt fur Gynakologie

Volumn 119, Issue 11, 1997, Pages 560-566

  Gremm, Birgit ^a   Sohn, Ch ^a   Beldermann, F ^a   Bastert, G ^a  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

Abdominal wall defect; Acetylcholinesterase; Alpha fetoprotein; Amniocentesis; Neural tube defect

Indexed keywords

ACETYLCHOLINESTERASE; ALPHA FETOPROTEIN;

ABDOMINAL WALL DEFECT; ADULT; AMNIOCENTESIS; ANENCEPHALUS; ARTICLE; CONGENITAL MALFORMATION; ENCEPHALOCELE; ENZYME ACTIVITY; FEMALE; FETUS ECHOGRAPHY; GASTROSCHISIS; HUMAN; MAJOR CLINICAL STUDY; MATERNAL AGE; NEURAL TUBE DEFECT; OMPHALOCELE; PRENATAL DIAGNOSIS; SPINA BIFIDA; TERATOMA; ABDOMINAL WALL MUSCULATURE; AMNION FLUID; BLOOD; CHORION VILLUS SAMPLING; ECHOGRAPHY; ENZYMOLOGY; GENETIC SCREENING; GESTATIONAL AGE; KARYOTYPING; METABOLISM; NEWBORN; PREGNANCY; RISK FACTOR; UMBILICAL HERNIA;

ABDOMINAL MUSCLES; ABNORMALITIES; ACETYLCHOLINESTERASE; ADULT; ALPHA-FETOPROTEINS; AMNIOCENTESIS; AMNIOTIC FLUID; CHORIONIC VILLI SAMPLING; FEMALE; GENETIC SCREENING; GESTATIONAL AGE; HERNIA, UMBILICAL; HUMANS; INFANT, NEWBORN; KARYOTYPING; NEURAL TUBE DEFECTS; PREGNANCY; PRENATAL DIAGNOSIS; RISK FACTORS; SPINAL DYSRAPHISM; ULTRASONOGRAPHY, PRENATAL;

EID: 0030778092     PISSN: 00444197     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Benn PA, Horne D, Briganti S, Rodis JF, Clive JM: Elevated second-trimester maternal serum hCG alone or in combination with elevated alpha-fetoprotein. Obstet Gynecol 87 (1996) 217-222
2. Blumenfeld Z, Zimmer E, Bronshtein M: A multidirectional sonographic approach to elevated amniotic alphafetoprotein or positive acetylcholinesterase. Obstet Gynecol 86 (1995) 565-568
3. Crandall BF, Chua C: Detecting neural tube defects by amniocentesis between 11 and 15 weeks' gestation. Prenat Diagn 15 (1995) 339-343
4. Gerhard I, Runnebaum B: Endokrine Marker zur Risikoermittlung in der Pränataldiagnostik. Gynäkol Praxis 19 (1995) 405-410
5. Gross SJ, Phillips OP, Shulman LP, Dungan JS, Simpson JL, Elias S: Adverse perinatal outcome in patients screen-positive for neural tube defects and fetal Down syndrome. Prenat Diagn 14 (1994) 609-613
6. Jorgensen FS, Sundberg K, Loft AG, Arenas J, Norgaard-Pedersen B: Alpha-fetoprotein and acetylcholinesterase activity in first- and early second- trimester amniotic fluid: Prenat Diagn 15 (1995) 621-625
7. Knörr K, Knörr-GärtnerH, Beller FK, Lauritzen C: Pränatale Diagnostik. In: Geburtshilfe und Gynäkologie. Hrsg.: Knörr K. Berlin - Heidelberg - New York: Springer 1989, 117-120
8. Krebs D: Anfragen an die Wertigkeit der Triple-Diagnostik in der Pränatalmedizin. Zentralbl Gynakol 117 (1995) 130-133
9. Loft AG, Hogdall E, Larsen SO, Norgaard-Petersen B: A comparison of amniotic fluid alpha-fetoprotein and acetylcholinesterase in the prenatal diagnosis of open neural tube defects and anterior abdominal wall defects. Prenat Diagn 13 (1993) 93-109
10. Lowry D, Campbell S, Krivchenia E, Dvorin E, Duquette D, Evans M: Impact of abnormal Second-Trimester Maternal Serum Single. Double and Triple Screening on patient choices about Prenatal Diagnosis. Fetal Diagn Ther 10 (1995) 286-289
11. Miller CM: Elevated maternal serum AFP and normal ultrasound: what next? Semin Ultrasound CT MR 14 (1993) 31-39
12. Reichler A., Hume RF Jr. Drugan A, Bardicef M, Isada NB, Johnson MP, Evans MI: Risk of anomalies as a function of level of elevated maternal serum alpha-fetoprotein. Am J Obstet Gynecol 171 (1994) 1052-1055
13. Robbin M, Filly RA, Fell S, Goldstein RB, Callen PW, Goldberg JD, Golbus MS: Elevated levels of amniotic fluid alpha-fetoprotein: sonographic evaluation. Radiology 188 (1993) 17-18
14. Sepulveda W, Donaldson A, Johnson RD. Davies G, Fisk NM: Are routine alpha-fetoprotein and acetylcholinesterase determinations still necessary at second-trimester amniocentesis? Impact of high-resolution ultrasonography. Obstet Gynecol 85 (1995) 107-112
15. Sohn C, Holzgreve W: Ultraschall in Gynäkologie und Geburtshilfe. Stuttgart - New York: Thieme 1995
16. Wald NJ, Hachshaw A, Stone R, Densem J: Serum alphafetoprotein and neural tube defects in the first trimester of pegnancy. Prenat Diagn 13 (1993) 1047-1050
17. Wathen NC, Campbell DJ, Kitau MJ, Chard T: Alphafetoprotein levels in amniotic fluid from 8 to 18 weeks of pregnancy. Br J Obstet Gynaecol 100 (1993) 380-382
18. Wenstrom KD, Owen J, Davis RO, Brumfield CG: Prognostic significance of unexplained elevated amniotic fluid alphafetoprotein. Obstet Gynecol 87 (1996) 213-216
19. Zwahr C, Voß P, Kistner G: Nichtinvasiver Serum-Test (NIS) zur pränatalen Erfassung von Morbus Down, anderen chromosomalen Anomalien und offenen Neuralrohrdefekten. Geburtshilfe Frauenheilkd 54 (1994) 355-361